Literature DB >> 11391225

Value of cardiac troponin I and T for selection of heart donors and as predictors of early graft failure.

E V Potapov1, E A Ivanitskaia, M Loebe, M Möckel, C Müller, R Sodian, R Meyer, R Hetzer.   

Abstract

BACKGROUND: Cardiac troponin I and T (cTnI and cTnT) are sensitive and specific markers of myocardial damage. We evaluated them for the selection of heart donors and as predictors of early graft failure after heart transplantation.
METHODS: cTnI, cTnT, myoglobin, and creatine kinase (CK) levels and its isoenzyme MB (CKMB) activity and mass were measured in serum samples immediately before opening the pericardium from 126 consecutive brain-dead multi-organ donors over 10 years of age inspected by our harvesting team. Donors with serum creatinine >2.0 mg/dL (n=6) were excluded from the analysis. Donors for high-urgency status recipients (n=2) were also excluded. The remaining donors were retrospectively divided into three groups: group I (n=68), grafts with good function; group II (n=11), grafts with impaired function; and group III (n=39), grafts not accepted for transplantation.
RESULTS: No differences in donor and recipient characteristics were found among the groups. The mean values of cTnI (0.36+/-0.88 microg/L, 4.45+/-3.28 microg/L, and 3.02+/-7.88 micog/L, respectively) and cTnT (0.016+/-0.029 microg/L, 0.134+/-0.114 microg/L, and 0.123+/-0.245 microg/L, respectively) were lower in group I when compared with groups II or III (cTnI: P<0.0001, P=0.018; cTnT: P<0.0001, P=0.012). The cTnI value was higher in group II compared with group III (P=0.023). The cTnT values were similar in groups II and III. A cTnI value >1.6 microg/L as a predictor of early graft failure had a specificity of 94%, and a cTnT value of >0.1 microg/L had a specificity of 99%. The odds ratio for the development of acute graft failure after heart transplantation was 42.7 for donors with cTnI >1.6 microg/L and 56.9 for donors with cTnT >0.1 microg/L. No differences of myoglobin, CKMB activity, or CKMB/CK ratio were found among the groups.
CONCLUSIONS: Significantly higher cTnI and cTnT values were found in peripheral blood at the time of explantation in donors of hearts with subsequently impaired graft function and in not accepted donors. cTnI and cTnT are useful as additional parameters for heart donor selection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391225     DOI: 10.1097/00007890-200105270-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  Troponin I levels from donors accepted for pediatric heart transplantation do not predict recipient graft survival.

Authors:  Kimberly Y Lin; Patrick Sullivan; Abdul Salam; Beth Kaufman; Stephen Paridon; Brian D Hanna; Thomas L Spray; Janice Weber; Robert Shaddy
Journal:  J Heart Lung Transplant       Date:  2011-04-13       Impact factor: 10.247

2.  Elevated Troponin? Take Heart and Reconsider!

Authors:  Shravani Pasupneti; Kiran Khush
Journal:  Circ Heart Fail       Date:  2016-06       Impact factor: 8.790

3.  Donor selection in the modern era.

Authors:  Kiran K Khush
Journal:  Ann Cardiothorac Surg       Date:  2018-01

4.  Donor predictors of allograft use and recipient outcomes after heart transplantation.

Authors:  Kiran K Khush; Rebecca Menza; John Nguyen; Jonathan G Zaroff; Benjamin A Goldstein
Journal:  Circ Heart Fail       Date:  2013-02-07       Impact factor: 8.790

5.  Pediatric cardiac transplantation using hearts previously refused for quality: a single center experience.

Authors:  R Easterwood; R K Singh; E D McFeely; W A Zuckerman; L J Addonizio; L Gilmore; K Beddows; J M Chen; M E Richmond
Journal:  Am J Transplant       Date:  2013-05-06       Impact factor: 8.086

Review 6.  Primary graft dysfunction after heart transplantation: a thorn amongst the roses.

Authors:  Sanjeet Singh Avtaar Singh; Jonathan R Dalzell; Colin Berry; Nawwar Al-Attar
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

7.  Cardiac Graft Assessment in the Era of Machine Perfusion: Current and Future Biomarkers.

Authors:  Martina Bona; Rahel K Wyss; Maria Arnold; Natalia Méndez-Carmona; Maria N Sanz; Dominik Günsch; Lucio Barile; Thierry P Carrel; Sarah L Longnus
Journal:  J Am Heart Assoc       Date:  2021-01-30       Impact factor: 5.501

8.  Acute ethanol exposure increases the susceptibility of the donor hearts to ischemia/reperfusion injury after transplantation in rats.

Authors:  Shiliang Li; Sevil Korkmaz; Sivakkanan Loganathan; Alexander Weymann; Tamás Radovits; Enikő Barnucz; Kristóf Hirschberg; Peter Hegedüs; Yan Zhou; Liang Tao; Szabolcs Páli; Gábor Veres; Matthias Karck; Gábor Szabó
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

9.  Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation.

Authors:  Enshi Wang; Yu Nie; Qian Zhao; Wei Wang; Jie Huang; Zhongkai Liao; Hao Zhang; Shengshou Hu; Zhe Zheng
Journal:  J Cardiothorac Surg       Date:  2013-07-01       Impact factor: 1.637

10.  C-Reactive protein level and left ventricular mass are associated with acute cellular rejection after heart transplant.

Authors:  Débora Cestari Bacal; Miguel Morita Fernandes-Silva; Sandrigo Mangini; Marcia Santos de Jesus; Fernando Bacal
Journal:  Clinics (Sao Paulo)       Date:  2021-12-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.